Chemotherapy and hemostasis disorders
Cancer patients are at risk of developing arterial and venous thrombosis during chemotherapy (CT) and after its cessation. A prothrombotic risk may arise via pathogenetic pathways such as activation of external and internal coagulation pathways, decreased anticoagulant levels, platelet activation, f...
Saved in:
| Main Authors: | E. V. Slukhanchuk, V. O. Bitsadze, A. G. Solopova, J. Kh. Khizroeva, K. N. Grigoreva, N. R. Gashimova, N. A. Makatsariya, D. V. Blinov, V. N. Galkin, A. Yu. Shatilina, E. M. Lyadnova, N. A. Shulga, L. T. Toguzaeva, S. Morkos, J.-C. Gris, I. Elalamy, G. Gerotziafas, A. D. Makatsariya |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IRBIS LLC
2025-01-01
|
| Series: | Акушерство, гинекология и репродукция |
| Subjects: | |
| Online Access: | https://www.gynecology.su/jour/article/view/2288 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Preeclampsia and venous thromboembolism
by: K. N. Grigoreva, et al.
Published: (2022-07-01) -
Thrombotic storm, hemostasis disorders and thromboinflammation in COVID-19
by: A. D. Makatsariya, et al.
Published: (2021-11-01) -
How to reduce a risk of venous thromboembolism while taking combined oral contraceptives
by: V. O. Bitsadze, et al.
Published: (2023-07-01) -
Haemostasis and metastasis: anticoagulants therapeutic potential in ovarian cancer
by: A. V. Vorobev, et al.
Published: (2025-07-01) -
Hemostasis parameters as prognostic biomarkers in gynecological cancer patients
by: E. V. Slukhanchuk, et al.
Published: (2023-05-01)